Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$120M
-
Value change
-
-$8.64M
-
Put/Call ratio
-
0.07
-
Number of buys
-
27
-
Number of sells
-
-11
-
Price
-
$9.60
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2022
55 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2022.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 27.7M outstanding shares and own 44.96% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic GP LLC (2.41M shares), Solas Capital Management, LLC (1.25M shares), Avoro Capital Advisors LLC (1.2M shares), DG Capital Management, LLC (1.02M shares), HARBERT FUND ADVISORS, INC. (317K shares), 683 Capital Management, LLC (300K shares), Opaleye Management Inc. (272K shares), Tamarack Advisers, LP (213K shares), and EAM Investors, LLC (176K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.